Estimating seroprevalence of SARS-CoV-2 antibodies using three self-reported symptoms: development of a prediction model based on data from Ischgl, Austria

por Lehmann, Jens, Giesinger, Johannes M., Rumpold, Gerhard, Borena, Wegene, Knabl, Ludwig, Falkensammer, Barbara, Ower, Cornelia, Sacher, Magdalena, von Laer, Dorothee, Sperner-Unterweger, Barbara, Holzner, Bernhard
Publicado 2021

Seroprevalence of SARS-CoV-2 infection in the Tyrolean district of Schwaz at the time of the rapid mass vaccination in March 2021 following B.1.351-variant outbreak

por Willeit, Peter, Kimpel, Janine, Winner, Hannes, Harthaller, Teresa, Schäfer, Helena, Bante, David, Falkensammer, Barbara, Rössler, Annika, Riepler, Lydia, Ower, Cornelia, Sacher, Magdalena, von Laer, Dorothee, Borena, Wegene
Publicado 2022

Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational phase 4 trial

por Seekircher, Lisa, Bánki, Zoltán, Kimpel, Janine, Rössler, Annika, Schäfer, Helena, Falkensammer, Barbara, Bante, David, Forer, Lukas, Schönherr, Sebastian, Harthaller, Teresa, Sacher, Magdalena, Ower, Cornelia, Tschiderer, Lena, Ulmer, Hanno, Krammer, Florian, von Laer, Dorothee, Borena, Wegene, Willeit, Peter
Publicado 2023